EP Patent

EP1363692B1 — Nasal delivery devices

Assigned to Optinose AS · Expires 2011-04-27 · 15y expired

What this patent protects

A nasal delivery device for delivering a substance to a nasal cavity of a subject, including: a nosepiece (240) adapted for insertion into a nostril of a subject; and a flow path fluidly connected to the nosepiece (240); wherein the nosepiece (240) is expandable and configured su…

USPTO Abstract

A nasal delivery device for delivering a substance to a nasal cavity of a subject, including: a nosepiece (240) adapted for insertion into a nostril of a subject; and a flow path fluidly connected to the nosepiece (240); wherein the nosepiece (240) is expandable and configured such as to expand on generation of a pressure in the flow path, thereby sealing with the nostril of the subject and providing for expansion of the nasal cavity of the subject.

Drugs covered by this patent

Patent Metadata

Patent number
EP1363692B1
Jurisdiction
EP
Classification
—
Expires
2011-04-27
Drug substance claim
No
Drug product claim
No
Assignee
Optinose AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.